How are biotechnology firms using viruses?
Many biotechnology and pharmaceutical firms use viruses to discover and then hone potential antibody-based pharmaceuticals. Q: How might the public benefit from this work? A: The public benefits primarily from training and education carried out in my lab, which supplies the California workplace with talented, high-tech workers to staff and start up new biomedical firms. Additionally, fundamental discoveries uncovered by our research inspire new strategies for anti-cancer and anti-viral therapies. Some already have been licensed and implemented by biomedical companies, which are pursuing ways to lower healthcare costs and improve treatment effectiveness. Q: What inspires your research? A: I read a lot of science fiction and often find myself thinking about ways to implement in my lab cool ideas from Ted Sturgeon, Neal Stephenson or Greg Benford. I also find my enjoyment of music and paintings focuses my research, perhaps by driving me to find creative, elegant solutions to complex probl